Biosimilar Antibody IgG1



Catalog-Number: BCMCBI1


BiCell Biosimilar Antibody IgG1

The BiCell Biosimilar Antibody IgG1 is a cutting-edge therapeutic product, designed to closely mimic the molecular structure and efficacy of an original monoclonal antibody. This biosimilar offers a high-quality, cost-effective alternative for various therapeutic applications.

Key Features
  • High Fidelity: Engineered to ensure structural and functional similarity to the reference antibody.
  • Enhanced Stability: Formulated for improved stability and extended shelf life.
  • Reduced Immunogenicity: Modified to minimize immune system reactions.
  • Versatile Applications: Suitable for a range of therapeutic areas, including oncology, autoimmunity, and inflammatory diseases.


The BiCell Biosimilar Antibody IgG1 is designed for therapeutic use in a wide array of medical conditions. Its applications include, but are not limited to, targeted cancer therapy, treatment of autoimmune diseases, and management of chronic inflammatory conditions.

Clonality: Monoclonal
Concentration: 0.25 mg/ml
Conjugation: Unconjugated
Isotype: IgG1
Purification: Affinity Chromatography
Reactivity: Human